Literature DB >> 22402723

[The present status and trend of brain tumors based on the data of the Brain Tumor Registry of Japan].

Soichiro Shibui1.   

Abstract

The Brain Tumor Registry of Japan (BTRJ) was founded in 1974 to investigate the statistical data of brain tumors in Japan. The 12th edition of the report was published as a supplement of the official journal of the Japan Neurosurgical Society, Neurologia medico-chirurgica, in October 2009. It contains the statistical data of 82,844 patients with primary or metastatic brain tumors registered between 1984 and 2000. The data represent the statistics of brain tumors such as the frequency and the anatomical distribution, patient age and sex, and survival rate in the magnetic resonance imaging (MRI) era. Among the registered cases, 65,677 were primary brain tumors. Meningioma was the most frequent, and it accounted for 27.1%, followed by glioma (26.6%), pituitary adenoma (18.2%), and schwannoma (10.5%). Among the patients who were under the age of 15 years the most frequent tumor was glioma (57.2%), while meningioma accounted for 46.3% among those over the age of 70 years. Compared with the data of the Central Brain Tumor Registry of the United States, glioma and meningioma were less frequent and pituitary adenoma and germ cell tumors were much more frequent in Japan. Both statistical registries showed that the frequency of benign brain tumors tends to increase and that of malignant tumors has decreased. In 2009, the BTRJ started the on-line registration, and most cases of brain tumors can be registered with the cooperation of all neurosurgeons in Japan.

Entities:  

Mesh:

Year:  2012        PMID: 22402723

Source DB:  PubMed          Journal:  Brain Nerve        ISSN: 1881-6096


  8 in total

Review 1.  Epidemiology and etiopathogenesis of pituitary adenomas.

Authors:  Elena D Aflorei; Márta Korbonits
Journal:  J Neurooncol       Date:  2014-01-31       Impact factor: 4.130

2.  Compressive Lesions of the Optic Chiasm: Subjective Symptoms and Visual Field Diagnostic Criteria.

Authors:  Mikiko Takahashi; Toshiaki Goseki; Hitoshi Ishikawa; Goukon Hiroyasu; Kazunori Hirasawa; Nobuyuki Shoji
Journal:  Neuroophthalmology       Date:  2018-09-11

3.  Stereotactic radiosurgery for non-vestibular cranial nerve schwanommas.

Authors:  Myreille D'Astous; Allen L Ho; Arjun Pendharkar; Clara Y H Choi; Scott G Soltys; Iris C Gibbs; Armine T Tayag; Patricia A Thompson; John R Adler; Steven D Chang
Journal:  J Neurooncol       Date:  2016-10-17       Impact factor: 4.130

4.  Factors Associated with and Temporal Trends in the Use of Radiation Therapy for the Treatment of Pituitary Adenoma in the National Cancer Database.

Authors:  Ramie Fathy; Edward Kuan; John Y K Lee; M Sean Grady; Michelle Alonso-Basanta; James N Palmer; Nithin D Adappa; Bert W O'Malley; Jason Brant
Journal:  J Neurol Surg B Skull Base       Date:  2019-10-04

5.  Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry.

Authors:  A Woehrer; M Hackl; T Waldhör; S Weis; J Pichler; A Olschowski; J Buchroithner; H Maier; G Stockhammer; C Thomé; J Haybaeck; F Payer; G von Campe; A Kiefer; F Würtz; G H Vince; R Sedivy; S Oberndorfer; F Marhold; K Bordihn; W Stiglbauer; U Gruber-Mösenbacher; R Bauer; J Feichtinger; A Reiner-Concin; W Grisold; C Marosi; M Preusser; K Dieckmann; I Slavc; B Gatterbauer; G Widhalm; C Haberler; J A Hainfellner
Journal:  Br J Cancer       Date:  2013-11-19       Impact factor: 7.640

6.  Long-Term Outcomes of Stereotactic Radiosurgery for Trigeminal, Facial, and Jugular Foramen Schwannoma in Comparison with Vestibular Schwannoma.

Authors:  Yuki Shinya; Hirotaka Hasegawa; Masahiro Shin; Takehiro Sugiyama; Mariko Kawashima; Atsuto Katano; Akinori Kashio; Kenji Kondo; Nobuhito Saito
Journal:  Cancers (Basel)       Date:  2021-03-07       Impact factor: 6.639

7.  A dural metastatic small cell carcinoma of the gallbladder as the first manifestation: a case report.

Authors:  Shuichi Tonomura; Tomoko Kitaichi; Rina Onishi; Yoshiaki Kakehi; Hisao Shimizu; Keiji Shimada; Kazuyuki Kanemasa; Akio Fukusumi; Nobuyuki Takahashi
Journal:  World J Surg Oncol       Date:  2018-03-16       Impact factor: 2.754

8.  A comparative, population-based analysis of pituitary incidentalomas vs clinically manifesting sellar masses.

Authors:  Nadine M Vaninetti; David B Clarke; Deborah A Zwicker; Churn-Ern Yip; Barna Tugwell; Steve Doucette; Chris Theriault; Khaled Aldahmani; Syed Ali Imran
Journal:  Endocr Connect       Date:  2018-04-30       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.